Latest Gene therapy Stories
PARIS, January 7, 2015 /PRNewswire/ -- This public - private project with an overall budget of EUR 47 million aims to restore vision to legally blind patients with
-- CHOP Gene Therapy Expert Fine-Tunes Protein Signals, Improves Motor Function and Reduces Brain Shrinkage in a Neurological Disorder -- PHILADELPHIA, Jan.
Using modified human stem cells, a team of UC Davis scientists has developed an improved gene therapy strategy that in animal models shows promise as a functional cure for the human immunodeficiency
In a new “proof of concept” experiment, scientists have managed to edit the genome of sperm-producing adult stem cells, creating a break in the DNA strands of a mutant gene in mouse cells then repairing it by replacing flawed segments with corrected ones.
Former head of rare diseases at Genzyme brings a 20-year track record of delivering successful, innovative products to patients throughout the world PHILADELPHIA, Dec.
Gene therapy pioneer and longtime Veterans Affairs researcher Dr. David Fink received the 2014 Paul B. Magnuson Award from VA in a ceremony at the VA Ann Arbor Healthcare System on Dec.
Leading gene therapy Company will partner with established market leader to develop a potential new treatment paradigm for hemophilia B PHILADELPHIA, Dec.
Data Demonstrate Therapeutic Levels of Clotting Factor for Hemophilia in Non-Human Primates and In Vivo Protein Production of Lysosomal Storage Disease Enzymes RICHMOND, Calif., Dec.
New campaign aims to increase awareness of immunotherapy and other gene and cell therapies. Stamford, CT (PRWEB) December 03, 2014 Alliance for Cancer
Dr. Daniel M. Takefman brings 15 years of FDA experience to leading gene therapy company PHILADELPHIA, Nov.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.
More Images (1 images) »